Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Lymphoedema Diagnostics Market: By Technology, By Disease Type, By End User and Geography
Download Free Sample Report
The lymphedema diagnostics market would grow at a CAGR of 7.8%.
2023 to 2029 is the growth period of the lymphedema diagnostics market.
The key driver for the lymphedema diagnostics market is the high prevalence of lymphedema and cancer, which are liable to impact the development of the lymphedema diagnostics industry optimistically.
North America is the fastest-growing regional market for the lymphedema diagnostics market.
1. Executive Summary |
2. Global Lymphoedema Diagnostics Market Introduction |
2.1. Global Lymphoedema Diagnostics Market – Taxonomy |
2.2. Global Lymphoedema Diagnostics Market –Definitions |
2.2.1. By Technology |
2.2.2. By Disease Type |
2.2.3. By End User |
2.2.4. By Region |
3. Global Lymphoedema Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Lymphoedema Diagnostics Market Dynamic Factors - Impact Analysis |
3.6. Global Lymphoedema Diagnostics Market – Competition Landscape |
4. Global Lymphoedema Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Lymphoedema Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. X-ray Lymphography |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Lymphoscintigraphy |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Computed Tomography |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Ultrasound Imaging |
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Magnetic Resonance Imaging. |
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Bioimpedance Analysis |
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Near-infrared Fluorescence Imaging |
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. ICG Lymphography |
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Fluorescein Sodium Microlymphangiography |
5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
6. Global Lymphoedema Diagnostics Market Forecast, By Disease Type, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
6.1. Cancer |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cardiovascular Disease |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Inflammatory Diseases |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Other Diseases |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Lymphoedema Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Hospitals |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centers |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Research & Academic Institutes |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Other End Users |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Lymphoedema Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Region, 2022-2028 |
9. North America Lymphoedema Diagnostics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. X-ray Lymphography |
9.1.2. Lymphoscintigraphy |
9.1.3. Computed Tomography |
9.1.4. Ultrasound Imaging |
9.1.5. Magnetic Resonance Imaging |
9.1.6. Bioimpedance Analysis |
9.1.7. Near-infrared Fluorescence Imaging |
9.1.8. ICG Lymphography |
9.1.9. Fluorescein Sodium Microlymphangiography |
9.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Cancer |
9.2.2. Cardiovascular Disease |
9.2.3. Inflammatory Diseases |
9.2.4. Other Diseases |
9.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Diagnostic Centers |
9.3.3. Research & Academic Institutes |
9.3.4. Other End Users |
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028 |
9.6. North America Lymphoedema Diagnostics Market Dynamics – Trends |
10. Europe Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. X-ray Lymphography |
10.1.2. Lymphoscintigraphy |
10.1.3. Computed Tomography |
10.1.4. Ultrasound Imaging |
10.1.5. Magnetic Resonance Imaging |
10.1.6. Bioimpedance Analysis |
10.1.7. Near-infrared Fluorescence Imaging |
10.1.8. ICG Lymphography |
10.1.9. Fluorescein Sodium Microlymphangiography |
10.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Cancer |
10.2.2. Cardiovascular Disease |
10.2.3. Inflammatory Diseases |
10.2.4. Other Diseases |
10.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Diagnostic Centers |
10.3.3. Research & Academic Institutes |
10.3.4. Other End Users |
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028 |
10.6. Europe Lymphoedema Diagnostics Market Dynamics – Trends |
11. Asia-Pacific Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. X-ray Lymphography |
11.1.2. Lymphoscintigraphy |
11.1.3. Computed Tomography |
11.1.4. Ultrasound Imaging |
11.1.5. Magnetic Resonance Imaging |
11.1.6. Bioimpedance Analysis |
11.1.7. Near-infrared Fluorescence Imaging |
11.1.8. ICG Lymphography |
11.1.9. Fluorescein Sodium Microlymphangiography |
11.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Cancer |
11.2.2. Cardiovascular Disease |
11.2.3. Inflammatory Diseases |
11.2.4. Other Diseases |
11.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Diagnostic Centers |
11.3.3. Research & Academic Institutes |
11.3.4. Other End Users |
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Lymphoedema Diagnostics Market - Opportunity Analysis Index, By Technology, By Disease Type, End User, and Country, 2022-2028 |
11.6. Asia-Pacific Lymphoedema Diagnostics Market Dynamics – Trends |
12. Latin America Lymphoedema Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. X-ray Lymphography |
12.1.2. Lymphoscintigraphy |
12.1.3. Computed Tomography |
12.1.4. Ultrasound Imaging |
12.1.5. Magnetic Resonance Imaging |
12.1.6. Bioimpedance Analysis |
12.1.7. Near-infrared Fluorescence Imaging |
12.1.8. ICG Lymphography |
12.1.9. Fluorescein Sodium Microlymphangiography |
12.2. By Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Cancer |
12.2.2. Cardiovascular Disease |
12.2.3. Inflammatory Diseases |
12.2.4. Other Diseases |
12.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Diagnostic Centers |
12.3.3. Research & Academic Institutes |
12.3.4. Other End Users |
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
Key Market Players